Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,660 | -14,096 | -6,741 | -28,669 | -19,142 |
| Depreciation Amortization | 847 | 560 | 283 | 1,604 | 1,348 |
| Accounts receivable | -155 | -27 | -600 | -1,424 | -1,235 |
| Other Working Capital | 165 | 132 | -550 | -5,629 | -4,724 |
| Other Operating Activity | 3,523 | 2,489 | 1,785 | 8,318 | 4,571 |
| Operating Cash Flow | $-15,280 | $-10,942 | $-5,823 | $-25,800 | $-19,182 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 7,273 | N/A |
| Debt Repayment | -489 | -372 | -206 | -44 | N/A |
| Common Stock Issued | 2,664 | 2,662 | 2,423 | 263 | 263 |
| Other Financing Activity | -220 | -146 | -73 | -461 | -240 |
| Financing Cash Flow | $1,955 | $2,144 | $2,144 | $7,031 | $23 |
| Exchange Rate Effect | 433 | 1,556 | 146 | -1,866 | -1,785 |
| Beginning Cash Position | 46,517 | 46,517 | 46,517 | 67,152 | 67,152 |
| End Cash Position | 33,625 | 39,275 | 42,984 | 46,517 | 46,208 |
| Net Cash Flow | $-12,892 | $-7,242 | $-3,533 | $-20,635 | $-20,944 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,280 | -10,942 | -5,823 | -25,800 | -19,182 |
| Free Cash Flow | -15,280 | -10,942 | -5,823 | -25,800 | -19,182 |